Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
March 21, 2017
Patent Application Number
14432664
Date Filed
October 3, 2013
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention provides compositions and methods for treating ovarian cancer. Specifically, the invention relates to administering a genetically modified T cell having alpha-folate receptor (FR-alpha) binding domain and CD27 costimulatory domain to treat ovarian cancer. In an embodiment, the FR-alpha binding domain is fully human, thereby preventing a host immune response.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
